Transparency and communication with investors are also critical on a scale-up journey. It’s important to keep investors informed and involved and regular updates about progress and challenges can ...

Offering free solutions can generate goodwill and strengthen relationships with both existing and potential customers. When a ...

Research from Brown University reveals no significant difference in overall cancer risk between red and white wine. However, ...

The programme includes the ECLIPSE 1 and ECLIPSE 2 Phase III trials, aiming to offer registrational data for regulatory ...

AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...

A new National Academies report recommends ways for the U.S. to reap the benefits of artificial intelligence in biotechnology ...

Senior Congress leader Ramesh Chennithala said here on Friday that a Dalit Progress Conclave will be held in Thiruvananthapuram on March 23 under the aegis of the Gandhi Gramam programme.

Analysts at Cantor Fitzgerald decreased their FY2025 EPS estimates for Codexis in a research note issued on Monday, March ...

Riyadh: Saudi Arabia has made significant strides in the biotechnology sector following the launch of its national strategy in early 2024, aiming to position itself as a leading global hub in the ...

Short sellers increased their bets against the broader healthcare sector in February vs. January, and Moderna remained the ...

Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms of regulated cell death for immune mediated ...

For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...